Doctor profile · Federal record
Dr. PETER HOUNTRAS, M.D.
Critical Care Medicine (Internal Medicine) Physician (CMS: PULMONARY DISEASE) · Internal Medicine Physician · Pulmonary Disease Physician · AURORA, CO
- NPI 1689973075
- Accepts Medicare
- MIPS 93.3 / 100 · 2023
- 15 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
12605 E 16TH AVE
AURORA, CO 80045
(720) 848-0000 - Mailing address
-
PO BOX 110429
AURORA, CO 800420429
Credentials & registration
- NPI registered
- March 2011 — 15 yrs on file
- Profile last updated
- November 16, 2018
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RC0200X — NUCC code
- State licenses (2)
- Colorado #DR.0053977 · Illinois #125059942
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689973075. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
894
Distinct HCPCS
10
Medicare allowed
$62,123
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
94375 |
Test to measure rate of airflow | 226 | 203 | $14 | |
94729 |
Test to examine how well the lungs exchange gases | 155 | 148 | $9 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 107 | 85 | $145 | |
94726 |
Test to determine lung volumes using sensors | 99 | 97 | $12 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 94 | 39 | $120 | |
99291 |
Critical care, first 30-74 minutes | 75 | 48 | $214 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 44 | 44 | $10 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 34 | 34 | $183 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 30 | 30 | $175 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 17 | 13 | $80 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 62. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$30,953
Transactions
99
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Inari Medical, Inc. | 28 | $8,899.91 | |
| Merck Sharp & Dohme LLC | 17 | $7,832.99 | |
| Actelion Pharmaceuticals US, Inc. | 23 | $7,792.65 | |
| United Therapeutics Corporation | 21 | $5,813.75 | |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $252.54 | |
| Imperative Care, Inc | 2 | $234.00 | |
| Janssen Pharmaceuticals, Inc | 2 | $44.14 | |
| Sandoz Inc. | 1 | $41.66 | |
| Penumbra, Inc. | 1 | $41.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
751
Patients
114
Total drug cost
$4,197,909
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Adempas (Riociguat) | Brand | 131 | 15 | $1,750,745 |
| Ambrisentan | Generic | 105 | 12 | $469,192 |
| Opsumit (Macitentan) | Brand | 84 | 15 | $1,059,939 |
| Eliquis (Apixaban) | Brand | 72 | 21 | $81,935 |
| Furosemide | Generic | 60 | 24 | $484 |
| Potassium Chloride | Generic | 59 | 15 | $3,891 |
| Sildenafil Citrate | Generic | 50 | 0 | $12,266 |
| Tadalafil | Generic | 47 | 0 | $41,329 |
| Xarelto (Rivaroxaban) | Brand | 37 | 12 | $36,107 |
| Uptravi (Selexipag) | Brand | 28 | 0 | $543,291 |